中文 | English
Return
Total: 681 , 1/69
Show Home Prev Next End page: GO
Author:(Shu-Hong YANG)

3.Progress in the study of tubulin inhibitors.

Hai SHANG ; Li PAN ; Shu YANG ; Hong CHEN ; Maosheng CHENG

Acta Pharmaceutica Sinica 2010;45(9):1078-88

5.Effects of mechanical stretch on expression of pentraxin-3 mRNA and protein in A549 cells

Huaqing SHU ; Qingping WU ; Lei YANG ; Hong ZHANG ; Shanglong YAO

Chinese Journal of Anesthesiology 2008;28(11):1023-1025

6.Study on stability of N-terminal site-specific PEGylated uncase

Jian YANG ; Shu ZHU ; Lei CAI ; Hong TIAN ; Wenbing YAO

Chinese Journal of Biochemical Pharmaceutics 2010;31(1):29-31

7.Literature Analysis of 132 Cases of Adverse Drug Reaction Induced by Monoclonal Antibody

Shu YANG ; Haiwen SHI ; Xiuqing GAO ; Ge HONG ; Shan GAO

China Pharmacy 2015;(23):3223-3225

8.Clinical Efficacy of Entecavir for Chronic Serious Hepatitis B

Hong WANG ; Shu YANG ; Xiuzhong ZENG ; Qiangsheng XU ; Zhemei HUANG

China Pharmacy 2007;0(26):-

9.Critical Antigenic Structure in Inducing Immune Damage of Peripheral Nerve Following Campylobacter Jejuni Infection

xiao-hong, WANG ; xiao-mei, SHU ; bing-zhu, YANG

Journal of Applied Clinical Pediatrics 2004;0(12):-

10.Analysis of clinical features of hepatitis B virus/hepatitis C virus coinfected patients with different virological profiles

Ka ZHANG ; Hong CAO ; Xiaoan YANG ; Lubiao CHEN ; Xiaolü HONG ; Xin SHU ; Gang LI ; Qihuan XU

Chinese Journal of Infectious Diseases 2011;29(7):429-432

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 681 , 1/69 Show Home Prev Next End page: GO